Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation

SIMPLE SUMMARY: Liver transplantation is considered the first-choice curative therapy for hepatocellular carcinoma in the early phase of the disease, when surgical resection is not possible. Even when implementing restrictive criteria to select patients for liver transplantation, there is a risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Degroote, Helena, Geerts, Anja, Verhelst, Xavier, Van Vlierberghe, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221160/
https://www.ncbi.nlm.nih.gov/pubmed/35740638
http://dx.doi.org/10.3390/cancers14122973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221160/
https://www.ncbi.nlm.nih.gov/pubmed/35740638
http://dx.doi.org/10.3390/cancers14122973

Ejemplares similares